Detalhe da pesquisa
1.
Impact of gender-neutral or girls-only vaccination against human papillomavirus-Results of a community-randomized clinical trial (I).
Int J Cancer
; 142(5): 949-958, 2018 03 01.
Artigo
em Inglês
| MEDLINE | ID: mdl-29055031
2.
Gender-neutral vaccination provides improved control of human papillomavirus types 18/31/33/35 through herd immunity: Results of a community randomized trial (III).
Int J Cancer
; 143(9): 2299-2310, 2018 11 01.
Artigo
em Inglês
| MEDLINE | ID: mdl-29845626
3.
Ten-year follow-up of human papillomavirus vaccine efficacy against the most stringent cervical neoplasia end-point-registry-based follow-up of three cohorts from randomized trials.
BMJ Open
; 7(8): e015867, 2017 Aug 18.
Artigo
em Inglês
| MEDLINE | ID: mdl-28821519
4.
Enrolment of 22,000 adolescent women to cancer registry follow-up for long-term human papillomavirus vaccine efficacy: guarding against guessing.
Int J STD AIDS
; 17(8): 517-21, 2006 Aug.
Artigo
em Inglês
| MEDLINE | ID: mdl-16925896
5.
Immunogenicity and safety of human papillomavirus (HPV)-16/18 AS04-adjuvanted vaccine in healthy boys aged 10-18 years.
J Adolesc Health
; 44(1): 33-40, 2009 01.
Artigo
em Inglês
| MEDLINE | ID: mdl-19101456